Global Nasal Decongestant Market Growth 2023-2029

February 2023 | 95 pages | ID: G5985A2CBD51EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Nasal decongestant is a type of pharmaceutical drug that is used to relieve nasal congestion in the upper respiratory tract. The active ingredient in most decongestants is either pseudoephedrine or phenylephrine (the latter of which has disputed effectiveness).

LPI (LP Information)' newest research report, the “Nasal Decongestant Industry Forecast” looks at past sales and reviews total world Nasal Decongestant sales in 2022, providing a comprehensive analysis by region and market sector of projected Nasal Decongestant sales for 2023 through 2029. With Nasal Decongestant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nasal Decongestant industry.

This Insight Report provides a comprehensive analysis of the global Nasal Decongestant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nasal Decongestant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nasal Decongestant market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nasal Decongestant and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nasal Decongestant.

The global Nasal Decongestant market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Nasal Decongestant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Nasal Decongestant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Nasal Decongestant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Nasal Decongestant players cover Abbott Laboratories, Glaxosmithkline, Cipla, Bayer, ADAPT Pharma, Patrick Parsons, Nidda Healthcare, Procter and Gamble and Rugby Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Nasal Decongestant market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Nasal Strips
• Tablet
• Spray
• Capsule

Segmentation by application

• Asthma
• Cold
• Nasal Allergies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott Laboratories
• Glaxosmithkline
• Cipla
• Bayer
• ADAPT Pharma
• Patrick Parsons
• Nidda Healthcare
• Procter and Gamble
• Rugby Laboratories

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nasal Decongestant market?

What factors are driving Nasal Decongestant market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nasal Decongestant market opportunities vary by end market size?

How does Nasal Decongestant break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nasal Decongestant Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Nasal Decongestant by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Nasal Decongestant by Country/Region, 2018, 2022 & 2029
2.2 Nasal Decongestant Segment by Type
  2.2.1 Nasal Strips
  2.2.2 Tablet
  2.2.3 Spray
  2.2.4 Capsule
2.3 Nasal Decongestant Sales by Type
  2.3.1 Global Nasal Decongestant Sales Market Share by Type (2018-2023)
  2.3.2 Global Nasal Decongestant Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Nasal Decongestant Sale Price by Type (2018-2023)
2.4 Nasal Decongestant Segment by Application
  2.4.1 Asthma
  2.4.2 Cold
  2.4.3 Nasal Allergies
2.5 Nasal Decongestant Sales by Application
  2.5.1 Global Nasal Decongestant Sale Market Share by Application (2018-2023)
  2.5.2 Global Nasal Decongestant Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Nasal Decongestant Sale Price by Application (2018-2023)

3 GLOBAL NASAL DECONGESTANT BY COMPANY

3.1 Global Nasal Decongestant Breakdown Data by Company
  3.1.1 Global Nasal Decongestant Annual Sales by Company (2018-2023)
  3.1.2 Global Nasal Decongestant Sales Market Share by Company (2018-2023)
3.2 Global Nasal Decongestant Annual Revenue by Company (2018-2023)
  3.2.1 Global Nasal Decongestant Revenue by Company (2018-2023)
  3.2.2 Global Nasal Decongestant Revenue Market Share by Company (2018-2023)
3.3 Global Nasal Decongestant Sale Price by Company
3.4 Key Manufacturers Nasal Decongestant Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Nasal Decongestant Product Location Distribution
  3.4.2 Players Nasal Decongestant Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR NASAL DECONGESTANT BY GEOGRAPHIC REGION

4.1 World Historic Nasal Decongestant Market Size by Geographic Region (2018-2023)
  4.1.1 Global Nasal Decongestant Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Nasal Decongestant Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nasal Decongestant Market Size by Country/Region (2018-2023)
  4.2.1 Global Nasal Decongestant Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Nasal Decongestant Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nasal Decongestant Sales Growth
4.4 APAC Nasal Decongestant Sales Growth
4.5 Europe Nasal Decongestant Sales Growth
4.6 Middle East & Africa Nasal Decongestant Sales Growth

5 AMERICAS

5.1 Americas Nasal Decongestant Sales by Country
  5.1.1 Americas Nasal Decongestant Sales by Country (2018-2023)
  5.1.2 Americas Nasal Decongestant Revenue by Country (2018-2023)
5.2 Americas Nasal Decongestant Sales by Type
5.3 Americas Nasal Decongestant Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nasal Decongestant Sales by Region
  6.1.1 APAC Nasal Decongestant Sales by Region (2018-2023)
  6.1.2 APAC Nasal Decongestant Revenue by Region (2018-2023)
6.2 APAC Nasal Decongestant Sales by Type
6.3 APAC Nasal Decongestant Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Nasal Decongestant by Country
  7.1.1 Europe Nasal Decongestant Sales by Country (2018-2023)
  7.1.2 Europe Nasal Decongestant Revenue by Country (2018-2023)
7.2 Europe Nasal Decongestant Sales by Type
7.3 Europe Nasal Decongestant Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nasal Decongestant by Country
  8.1.1 Middle East & Africa Nasal Decongestant Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Nasal Decongestant Revenue by Country (2018-2023)
8.2 Middle East & Africa Nasal Decongestant Sales by Type
8.3 Middle East & Africa Nasal Decongestant Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nasal Decongestant
10.3 Manufacturing Process Analysis of Nasal Decongestant
10.4 Industry Chain Structure of Nasal Decongestant

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Nasal Decongestant Distributors
11.3 Nasal Decongestant Customer

12 WORLD FORECAST REVIEW FOR NASAL DECONGESTANT BY GEOGRAPHIC REGION

12.1 Global Nasal Decongestant Market Size Forecast by Region
  12.1.1 Global Nasal Decongestant Forecast by Region (2024-2029)
  12.1.2 Global Nasal Decongestant Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nasal Decongestant Forecast by Type
12.7 Global Nasal Decongestant Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Information
  13.1.2 Abbott Laboratories Nasal Decongestant Product Portfolios and Specifications
  13.1.3 Abbott Laboratories Nasal Decongestant Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Abbott Laboratories Main Business Overview
  13.1.5 Abbott Laboratories Latest Developments
13.2 Glaxosmithkline
  13.2.1 Glaxosmithkline Company Information
  13.2.2 Glaxosmithkline Nasal Decongestant Product Portfolios and Specifications
  13.2.3 Glaxosmithkline Nasal Decongestant Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Glaxosmithkline Main Business Overview
  13.2.5 Glaxosmithkline Latest Developments
13.3 Cipla
  13.3.1 Cipla Company Information
  13.3.2 Cipla Nasal Decongestant Product Portfolios and Specifications
  13.3.3 Cipla Nasal Decongestant Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Cipla Main Business Overview
  13.3.5 Cipla Latest Developments
13.4 Bayer
  13.4.1 Bayer Company Information
  13.4.2 Bayer Nasal Decongestant Product Portfolios and Specifications
  13.4.3 Bayer Nasal Decongestant Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Bayer Main Business Overview
  13.4.5 Bayer Latest Developments
13.5 ADAPT Pharma
  13.5.1 ADAPT Pharma Company Information
  13.5.2 ADAPT Pharma Nasal Decongestant Product Portfolios and Specifications
  13.5.3 ADAPT Pharma Nasal Decongestant Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 ADAPT Pharma Main Business Overview
  13.5.5 ADAPT Pharma Latest Developments
13.6 Patrick Parsons
  13.6.1 Patrick Parsons Company Information
  13.6.2 Patrick Parsons Nasal Decongestant Product Portfolios and Specifications
  13.6.3 Patrick Parsons Nasal Decongestant Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Patrick Parsons Main Business Overview
  13.6.5 Patrick Parsons Latest Developments
13.7 Nidda Healthcare
  13.7.1 Nidda Healthcare Company Information
  13.7.2 Nidda Healthcare Nasal Decongestant Product Portfolios and Specifications
  13.7.3 Nidda Healthcare Nasal Decongestant Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Nidda Healthcare Main Business Overview
  13.7.5 Nidda Healthcare Latest Developments
13.8 Procter and Gamble
  13.8.1 Procter and Gamble Company Information
  13.8.2 Procter and Gamble Nasal Decongestant Product Portfolios and Specifications
  13.8.3 Procter and Gamble Nasal Decongestant Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Procter and Gamble Main Business Overview
  13.8.5 Procter and Gamble Latest Developments
13.9 Rugby Laboratories
  13.9.1 Rugby Laboratories Company Information
  13.9.2 Rugby Laboratories Nasal Decongestant Product Portfolios and Specifications
  13.9.3 Rugby Laboratories Nasal Decongestant Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Rugby Laboratories Main Business Overview
  13.9.5 Rugby Laboratories Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Nasal Decongestant Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nasal Decongestant Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Nasal Strips
Table 4. Major Players of Tablet
Table 5. Major Players of Spray
Table 6. Major Players of Capsule
Table 7. Global Nasal Decongestant Sales by Type (2018-2023) & (K Units)
Table 8. Global Nasal Decongestant Sales Market Share by Type (2018-2023)
Table 9. Global Nasal Decongestant Revenue by Type (2018-2023) & ($ million)
Table 10. Global Nasal Decongestant Revenue Market Share by Type (2018-2023)
Table 11. Global Nasal Decongestant Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Nasal Decongestant Sales by Application (2018-2023) & (K Units)
Table 13. Global Nasal Decongestant Sales Market Share by Application (2018-2023)
Table 14. Global Nasal Decongestant Revenue by Application (2018-2023)
Table 15. Global Nasal Decongestant Revenue Market Share by Application (2018-2023)
Table 16. Global Nasal Decongestant Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Nasal Decongestant Sales by Company (2018-2023) & (K Units)
Table 18. Global Nasal Decongestant Sales Market Share by Company (2018-2023)
Table 19. Global Nasal Decongestant Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Nasal Decongestant Revenue Market Share by Company (2018-2023)
Table 21. Global Nasal Decongestant Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Nasal Decongestant Producing Area Distribution and Sales Area
Table 23. Players Nasal Decongestant Products Offered
Table 24. Nasal Decongestant Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Nasal Decongestant Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Nasal Decongestant Sales Market Share Geographic Region (2018-2023)
Table 29. Global Nasal Decongestant Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Nasal Decongestant Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Nasal Decongestant Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Nasal Decongestant Sales Market Share by Country/Region (2018-2023)
Table 33. Global Nasal Decongestant Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Nasal Decongestant Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Nasal Decongestant Sales by Country (2018-2023) & (K Units)
Table 36. Americas Nasal Decongestant Sales Market Share by Country (2018-2023)
Table 37. Americas Nasal Decongestant Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Nasal Decongestant Revenue Market Share by Country (2018-2023)
Table 39. Americas Nasal Decongestant Sales by Type (2018-2023) & (K Units)
Table 40. Americas Nasal Decongestant Sales by Application (2018-2023) & (K Units)
Table 41. APAC Nasal Decongestant Sales by Region (2018-2023) & (K Units)
Table 42. APAC Nasal Decongestant Sales Market Share by Region (2018-2023)
Table 43. APAC Nasal Decongestant Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Nasal Decongestant Revenue Market Share by Region (2018-2023)
Table 45. APAC Nasal Decongestant Sales by Type (2018-2023) & (K Units)
Table 46. APAC Nasal Decongestant Sales by Application (2018-2023) & (K Units)
Table 47. Europe Nasal Decongestant Sales by Country (2018-2023) & (K Units)
Table 48. Europe Nasal Decongestant Sales Market Share by Country (2018-2023)
Table 49. Europe Nasal Decongestant Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Nasal Decongestant Revenue Market Share by Country (2018-2023)
Table 51. Europe Nasal Decongestant Sales by Type (2018-2023) & (K Units)
Table 52. Europe Nasal Decongestant Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Nasal Decongestant Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Nasal Decongestant Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Nasal Decongestant Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Nasal Decongestant Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Nasal Decongestant Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Nasal Decongestant Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Nasal Decongestant
Table 60. Key Market Challenges & Risks of Nasal Decongestant
Table 61. Key Industry Trends of Nasal Decongestant
Table 62. Nasal Decongestant Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Nasal Decongestant Distributors List
Table 65. Nasal Decongestant Customer List
Table 66. Global Nasal Decongestant Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Nasal Decongestant Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Nasal Decongestant Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Nasal Decongestant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Nasal Decongestant Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Nasal Decongestant Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Nasal Decongestant Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Nasal Decongestant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Nasal Decongestant Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Nasal Decongestant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Nasal Decongestant Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Nasal Decongestant Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Nasal Decongestant Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Nasal Decongestant Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Abbott Laboratories Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 81. Abbott Laboratories Nasal Decongestant Product Portfolios and Specifications
Table 82. Abbott Laboratories Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Abbott Laboratories Main Business
Table 84. Abbott Laboratories Latest Developments
Table 85. Glaxosmithkline Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 86. Glaxosmithkline Nasal Decongestant Product Portfolios and Specifications
Table 87. Glaxosmithkline Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Glaxosmithkline Main Business
Table 89. Glaxosmithkline Latest Developments
Table 90. Cipla Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 91. Cipla Nasal Decongestant Product Portfolios and Specifications
Table 92. Cipla Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Cipla Main Business
Table 94. Cipla Latest Developments
Table 95. Bayer Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 96. Bayer Nasal Decongestant Product Portfolios and Specifications
Table 97. Bayer Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Bayer Main Business
Table 99. Bayer Latest Developments
Table 100. ADAPT Pharma Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 101. ADAPT Pharma Nasal Decongestant Product Portfolios and Specifications
Table 102. ADAPT Pharma Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. ADAPT Pharma Main Business
Table 104. ADAPT Pharma Latest Developments
Table 105. Patrick Parsons Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 106. Patrick Parsons Nasal Decongestant Product Portfolios and Specifications
Table 107. Patrick Parsons Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Patrick Parsons Main Business
Table 109. Patrick Parsons Latest Developments
Table 110. Nidda Healthcare Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 111. Nidda Healthcare Nasal Decongestant Product Portfolios and Specifications
Table 112. Nidda Healthcare Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Nidda Healthcare Main Business
Table 114. Nidda Healthcare Latest Developments
Table 115. Procter and Gamble Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 116. Procter and Gamble Nasal Decongestant Product Portfolios and Specifications
Table 117. Procter and Gamble Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Procter and Gamble Main Business
Table 119. Procter and Gamble Latest Developments
Table 120. Rugby Laboratories Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 121. Rugby Laboratories Nasal Decongestant Product Portfolios and Specifications
Table 122. Rugby Laboratories Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Rugby Laboratories Main Business
Table 124. Rugby Laboratories Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Nasal Decongestant
Figure 2. Nasal Decongestant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nasal Decongestant Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Nasal Decongestant Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nasal Decongestant Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Nasal Strips
Figure 10. Product Picture of Tablet
Figure 11. Product Picture of Spray
Figure 12. Product Picture of Capsule
Figure 13. Global Nasal Decongestant Sales Market Share by Type in 2022
Figure 14. Global Nasal Decongestant Revenue Market Share by Type (2018-2023)
Figure 15. Nasal Decongestant Consumed in Asthma
Figure 16. Global Nasal Decongestant Market: Asthma (2018-2023) & (K Units)
Figure 17. Nasal Decongestant Consumed in Cold
Figure 18. Global Nasal Decongestant Market: Cold (2018-2023) & (K Units)
Figure 19. Nasal Decongestant Consumed in Nasal Allergies
Figure 20. Global Nasal Decongestant Market: Nasal Allergies (2018-2023) & (K Units)
Figure 21. Global Nasal Decongestant Sales Market Share by Application (2022)
Figure 22. Global Nasal Decongestant Revenue Market Share by Application in 2022
Figure 23. Nasal Decongestant Sales Market by Company in 2022 (K Units)
Figure 24. Global Nasal Decongestant Sales Market Share by Company in 2022
Figure 25. Nasal Decongestant Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Nasal Decongestant Revenue Market Share by Company in 2022
Figure 27. Global Nasal Decongestant Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Nasal Decongestant Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Nasal Decongestant Sales 2018-2023 (K Units)
Figure 30. Americas Nasal Decongestant Revenue 2018-2023 ($ Millions)
Figure 31. APAC Nasal Decongestant Sales 2018-2023 (K Units)
Figure 32. APAC Nasal Decongestant Revenue 2018-2023 ($ Millions)
Figure 33. Europe Nasal Decongestant Sales 2018-2023 (K Units)
Figure 34. Europe Nasal Decongestant Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Nasal Decongestant Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Nasal Decongestant Revenue 2018-2023 ($ Millions)
Figure 37. Americas Nasal Decongestant Sales Market Share by Country in 2022
Figure 38. Americas Nasal Decongestant Revenue Market Share by Country in 2022
Figure 39. Americas Nasal Decongestant Sales Market Share by Type (2018-2023)
Figure 40. Americas Nasal Decongestant Sales Market Share by Application (2018-2023)
Figure 41. United States Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Nasal Decongestant Sales Market Share by Region in 2022
Figure 46. APAC Nasal Decongestant Revenue Market Share by Regions in 2022
Figure 47. APAC Nasal Decongestant Sales Market Share by Type (2018-2023)
Figure 48. APAC Nasal Decongestant Sales Market Share by Application (2018-2023)
Figure 49. China Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Nasal Decongestant Sales Market Share by Country in 2022
Figure 57. Europe Nasal Decongestant Revenue Market Share by Country in 2022
Figure 58. Europe Nasal Decongestant Sales Market Share by Type (2018-2023)
Figure 59. Europe Nasal Decongestant Sales Market Share by Application (2018-2023)
Figure 60. Germany Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Nasal Decongestant Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Nasal Decongestant Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Nasal Decongestant Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Nasal Decongestant Sales Market Share by Application (2018-2023)
Figure 69. Egypt Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Nasal Decongestant Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Nasal Decongestant in 2022
Figure 75. Manufacturing Process Analysis of Nasal Decongestant
Figure 76. Industry Chain Structure of Nasal Decongestant
Figure 77. Channels of Distribution
Figure 78. Global Nasal Decongestant Sales Market Forecast by Region (2024-2029)
Figure 79. Global Nasal Decongestant Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Nasal Decongestant Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Nasal Decongestant Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Nasal Decongestant Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Nasal Decongestant Revenue Market Share Forecast by Application (2024-2029)